The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis

K Schinnerling, JC Aguillón, D Catalán… - Clinical & experimental …, 2017 - academic.oup.com
Therapeutic blockage of cytokine signalling in autoimmune diseases has improved our
understanding of the role of these cytokines in triggering, shaping and perpetuating …

Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases

Y Lai, C Dong - International immunology, 2016 - academic.oup.com
Inflammatory cytokines are key regulators of immune responses. Persistent and excessive
production of inflammatory cytokines underscores the development of autoimmune …

The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases

É Toussirot - Inflammation & Allergy-Drug Targets (Formerly …, 2012 - ingentaconnect.com
IL-23 is a pro-inflammatory cytokine belonging to the IL-12 cytokine family. IL-23 is essential
for the differentiation of Th17 lymphocytes, a subtype of T lymphocyte implicated in chronic …

Emerging cytokine targets in rheumatoid arthritis

DL Asquith, IB McInnes - Current opinion in rheumatology, 2007 - journals.lww.com
Novel cytokine activities are emerging on an ongoing basis. There remain difficulties in
ascribing the optimal regulatory hierarchy for given moieties on the basis of existing …

Role of pro-inflammatory cytokines in rheumatoid arthritis

FM Brennan, RN Maini, M Feldmann - Springer seminars in …, 1998 - Springer
Rheumatoid arthritis (RA) is well known to be a chronic autoimmune/inflammatory disease
which leads to progressive joint damage and destruction. Less well known is the fact that in …

Novel immunotherapeutic avenues for rheumatoid arthritis

L Semerano, E Minichiello, N Bessis… - Trends in Molecular …, 2016 - cell.com
Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease. It leads to
irreversible joint damage, physical handicap, and reduced life expectancy. The past two …

The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover

PKK Wong, IK Campbell, PJ Egan… - Arthritis and …, 2003 - research.monash.edu
There is increasing evidence that the IL-6 family of cytokines and signaling pathways
downstream of the common gp130 receptor subunit are important in joint development, in …

[HTML][HTML] What is the future of targeted therapy in rheumatology: biologics or small molecules?

A Mócsai, L Kovács, P Gergely - BMC medicine, 2014 - Springer
Background Until late in the 20th century, the therapy of rheumatic diseases relied on the
use of drugs that had been developed through empirical approaches without detailed …

[HTML][HTML] Mini review: new treatments in psoriatic arthritis. focus on the IL-23/17 axis

LI Sakkas, E Zafiriou, DP Bogdanos - Frontiers in pharmacology, 2019 - frontiersin.org
Psoriasis, an inflammatory skin disease, and psoriatic arthritis (PsA), an inflammatory
arthritis, share clinical, genetic, and pathogenic factors and may be summed as one disease …

Rheumatoid arthritis: current and future trends

K Chaudhari, S Rizvi, BA Syed - Nat Rev Drug Discov, 2016 - nature.com
Rheumatoid arthritis (RA) is a chronic autoimmune condition of the connective tissue in
synovial joints characterized by inflammation that can lead to impaired movement and …